Evaluating the Use of a CPOE for Chemotherapy Protocols.


Journal

Studies in health technology and informatics
ISSN: 1879-8365
Titre abrégé: Stud Health Technol Inform
Pays: Netherlands
ID NLM: 9214582

Informations de publication

Date de publication:
16 Jun 2020
Historique:
entrez: 24 6 2020
pubmed: 24 6 2020
medline: 21 8 2020
Statut: ppublish

Résumé

Chemotherapy drugs are one of the most common causes of serious and fatal medication errors, especially during prescribing, where computerized physician order entry (CPOE) take on importance. This study proposes the description of the post-implementation status of a CPOE in a highly specialized hospital between January and June 2018, among patients older than 18 years. Results: a total of 8835 protocols were indicated using the specific CPOE (93% use rate over all protocols) 91% completed the administration, 1.2% were rejected by pharmacy, and 6.8% was canceled. The most frequent cause of rejection by pharmacy and cancellation by oncologist was an inadequate dose. Most of the protocols indicated using the CPOE implemented, with a reject by pharmacy rate of 1.2%, indicates the utility of CPOE as an error prevention strategy.

Identifiants

pubmed: 32570614
pii: SHTI200397
doi: 10.3233/SHTI200397
doi:

Substances chimiques

Antineoplastic Agents 0

Types de publication

Journal Article

Langues

eng

Pagination

1271-1272

Auteurs

C Gimenez (C)

Department of Biomedical Informatics, Hospital Italiano de Buenos Aires, Argentina.

S de Matos Lima (S)

Department of Biomedical Informatics, Hospital Italiano de Buenos Aires, Argentina.

D Luna (D)

Department of Biomedical Informatics, Hospital Italiano de Buenos Aires, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs
Humans Male Female Health Knowledge, Attitudes, Practice Middle Aged
Humans Female Alopecia Breast Neoplasms Middle Aged
Neoplastic Stem Cells Animals Humans Aldehyde Dehydrogenase Tretinoin

Classifications MeSH